Association of the CCR5delta32 mutation with improved response to antiretroviral therapy.
Valdez
H
H
Purvis
S F
SF
Lederman
M M
MM
Fillingame
M
M
Zimmerman
P A
PA
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018450:Disease Progression; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics* / Q000276:immunology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1; D006801:Humans; D009154:Mutation; D019713:Receptors, CCR5 / Q000235:genetics*; D016896:Treatment Outcome; D019562:Viral Load
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019713:Receptors, CCR5